A new drug for the treatment of Bekhterev's disease is successfully undergoing the third phase of clinical trials. This was announced by the director of the Nasonova Research Institute of Rheumatology, Corresponding Member of the Russian Academy of Sciences Alexander Lila.
Such a drug was developed by the domestic company «Biocad» and has been undergoing clinical trials for several years. Today, we are completing the second phase, the third phase is underway, and in these two phases, more than 600 patients in the Russian Federation are already receiving this drug.
The drug is prescribed to patients who have not undergone treatment using genetic engineering therapy. Currently, four medical centers in Moscow, St. Petersburg and Novosibirsk are conducting such therapy in hospitals.
The drug is administered intravenously via a drip. The second infusion — drug administration — is carried out three months after the first, and then every six months. Treatment can continue for several years, but patients can lead a full life.
Bekhterev's disease — is a chronic disease of the spine and joints. Its main symptoms are: lower back pain, which worsens at night and in the morning, and stiffness of movements. Most often, the disease affects young men, the exact cause of the disease is unknown, a key role is played by genetic predisposition.
Read more materials on the topic:
- An analogue of a foreign drug for the treatment of thrombosis was created at SibGMU
- The first domestic analogue of the American drug against head cancer "Cetuximab" received registration from the Ministry of Health
- AI for diagnosing brain tumors was created by scientists from NNSU
Now on home
Further purchases will depend on the foreign policy situation
Method works with 99.5% accuracy
China accounts for about 27% of Russian exports and 36% of imports
The company is to complete the work on the "Altius" drone, which has been under development since 2011
Non-Energy Exports Break Through Sanctions
The Ministry of Transport reported that the flight schedule will be completed by the end of the week
Automated system controls microclimate and CO₂ levels in the insulated van
Poorly developed charging infrastructure may slow sales growth
Problems with transportation through the Strait of Hormuz have complicated supplies
The "Mir-Gluboky" project, worth 126 billion rubles, will be submitted for consideration
Thousands of students are already using the chip for laboratory and practical work
The changes to the carrier's transportation rules apply to all flights